Momelotinib Impurity 10 | CAS 102078-13-7 - Request Quote
Momelotinib Impurity 10
| SZ CAT No: | SZ-M168021 |
| CAS No | 102078-13-7 |
| Mol.F. | C20H18O5 |
| Mol.Wt. | 338.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Momelotinib Impurity 10 is chemically Dimethyl 4,4'-(1-oxobut-2-ene-1,3-diyl)dibenzoate. Momelotinib Impurity 10 is supplied with detailed characterization data compliant with regulatory guideline. Momelotinib Impurity 10 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Momelotinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 102078-13-7
Purchase 102078-13-7
Order 102078-13-7
Enquire 102078-13-7
price of 102078-13-7
102078-13-7 Supplier
102078-13-7 Manufacturer
102078-13-7 Exporter
buy high quality Momelotinib Impurity 10
Purchase Momelotinib Impurity 10
Momelotinib Impurity 10 suppliers
Momelotinib Impurity 10 manufacturers
Momelotinib Impurity 10 price
Order Momelotinib Impurity 10
Enquire Momelotinib Impurity 10
Momelotinib Impurity 10 cost
Momelotinib Impurity 10 Supplier
Momelotinib Impurity 10 Distributor
Momelotinib Impurity 10 for Method Validation
Momelotinib Reference Standard
Momelotinib Impurity 10 for ANDA Filing
Momelotinib Impurity 10 for Forced Degradation Studies
Momelotinib Impurity 10 Identification Standards
Momelotinib Impurity 10 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.